According to work completed in mice by researchers at the Stanford University College of Medication.
Rossi, Weissman and the other first writer, postdoctoral scholar David Bryder, PhD, tested that idea in two different pieces of experiments. In the first, they studied the blood-forming stem cells of mice designed to have one mutations that make them especially susceptible to accumulating additional genetic mistakes. In each of the three various kinds of mutant mice they studied, the stem cells seemed to behave and to produce new blood cells normally. However, the full truth came out when they took blood-forming stem cells from any of the three types of mice and used those cells to repopulate the bone marrow of irradiated mice.This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an unbiased news service editorially, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.
Aerosol vaccine provides low-cost, needle-free TB treatment A novel aerosol version of the most common tuberculosis vaccine, administered directly to the lung area as an oral mist, offers significantly better safety against the disease in experimental animals than a comparable dose of the traditional injected vaccine, researchers record this full week in the Proceedings of the National Academy of Sciences.